INMB
Inmune Bio, Inc.Company with tickers: INMB
Market Cap
$39.61M
Shares Outstanding
26,585,258
CIK
1711754
CUSIP
45782T105
13F Activity (30d)
3 filings
2 filers
Website
Visit website
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marcia Allen | Director | Appointed | 2026-06-17 |
| Scott Juda, JD | Director | Appointed | 2026-06-17 |
| Tim Schroeder | Director | Appointed | 2026-06-17 |
| J. Kelly Ganjei | Director | Appointed | 2026-06-17 |
| David Moss | Director | Appointed | 2026-06-17 |